Proneuron Biotechnologies

Proneuron Biotechnologies is a biopharmaceutical company developing therapies for neurological disorders, including spinal cord injuries (SCI), brain trauma, and neurodegenerative diseases such as ALS, Huntington’s and Alzheimer’s diseases. The brain, spinal cord and optic nerves comprise the central nervous system (CNS) one of the most complex and enigmatic systems in nature. The CNS is responsible for consciousness, memory, intelligence, the five senses, and controlled movement. However, these functions may be disrupted by brain damage, spinal injury or disease, causing severe disability, such as paralysis, blindness, or loss of mental capabilities. The disability is often permanent because the CNS has a very limited capacity for healing and self repair.While there is no paralysis cure yet available to treat spinal cord injury, nor any cure for CNS trauma in general, scientists at the Weizmann Institute of Science and Proneuron have demonstrated that CNS recovery may be enhanced by applying the body’s own repair system, the immune system, which is actively involved in wound-healing in other parts of the body. In the quest for a paralysis cure, Proneuron is pursuing an aggressive research and development program based on proprietary immune-modulating technology. Proneuron's lead product is ProCord, an experimental cell therapy that is being developed to treat acute spinal cord injury. Besides spinal cord injuries, additional products are being developed for other debilitating neurological indications

Contact Details: Weizmann Science Park, Building 14,P.O.B. 277 Ness-Ziona 74101 Israel Tel: 972-8-9409550 Fax: 972-8-9409560 Email: information@proneuron.com WWW: www.proneuron.com/

Recent Publications by Proneuron Biotechnologies:
Features of skin-coincubated macrophages that promote recovery from spinal cord injury. Uncontrolled inflammation is considered to exacerbate the neuronal loss...	6th January, 2004	Proneuron Biotechnologies, P.O. Box 277, Ness Ziona 74101, Israel.	J Neuroimmunol. 2003 Sep;142(1-2):10-6.

Press Releases on Proneuron Biotechnologies:
Phase I ProCord Study Results Published in the Journal of Neurosurgery:	1st September, 2005	Proneuron Biotechnologies	Phase I ProCord Study Results Published in the Journal of Neurosurgery: Spine September 2005 Issue L.A., California, September 12,

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 528 times since April 2007, the link to the organisation's website has been followed 84 times

Recent Search Terms used to find this page: Weizmann Science Park in Nes Ziona | proneuron | proneuron | ProNeuron Biotechnologies | f | Proneuron Biotechnologies | Proneuron | Proneuron Biotechnologies details contact | Proneuron 2009 | .

Search for more companies in Ness-Ziona

Search for more companies in

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Proneuron Biotechnologies